Oramed Pharmaceuticals Inc (ORMP) — Cash Flow Reinvestment Rate
Oramed Pharmaceuticals Inc (ORMP) has a Cash Flow Reinvestment Rate of 45.70x as of June 2024, reinvesting $94.66 Million (capex $17.06 plus investments $94.66 Million) from operating cash flow of $2.07 Million. Check Oramed Pharmaceuticals Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oramed Pharmaceuticals Inc Cash Flow Reinvestment Rate (2016–2016)
Historical reinvestment intensity for Oramed Pharmaceuticals Inc across 1 annual periods. Explore Oramed Pharmaceuticals Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Oramed Pharmaceuticals Inc (2016–2016)
Year-by-year capital reinvestment analysis for Oramed Pharmaceuticals Inc. For live market cap and broader valuation context, see ORMP market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.00x | $9.00K | $4.66 Million | $9.00K | — |